These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function. Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK. Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698 [Abstract] [Full Text] [Related]
6. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa]. Reinert P. Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081 [Abstract] [Full Text] [Related]
7. [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)]. Sermet-Gaudelus I, Ferroni A, Vrielinck S, Lebourgeois M, Chedevergne F, Lenoir G. Arch Pediatr; 2006 Oct; 13 Suppl 1():S30-43. PubMed ID: 17370394 [Abstract] [Full Text] [Related]
11. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis. Lahiri T. Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550 [Abstract] [Full Text] [Related]
12. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN, Ratjen F. Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546 [Abstract] [Full Text] [Related]
13. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis. Ratjen F. Curr Opin Pulm Med; 2006 Nov; 12(6):428-32. PubMed ID: 17053493 [Abstract] [Full Text] [Related]